三鑫醫療(300453.SZ)控股子公司完成醫療器械變更註冊
格隆匯11月4日丨三鑫醫療(300453.SZ)公佈,公司控股子公司黑龍江鑫品晰醫療科技有限公司(“鑫品晰”)原名黑龍江三鑫醫療科技有限公司(“黑龍江三鑫”),因經營發展需要,黑龍江三鑫已更名為鑫品晰並完成了工商變更登記。
黑龍江三鑫更名為鑫品晰後,其所持有的醫療器械註冊證需進行相應變更。近日,鑫品晰取得了國家藥品監督管理局頒發的《醫療器械註冊變更文件》,註冊證編號:國械注準20193100207;產品名稱:血液透析濃縮液;變更內容:“註冊人名稱:黑龍江三鑫醫療科技有限公司;”變更為“註冊人名稱:黑龍江鑫品晰醫療科技有限公司”;備註:按新《分類目錄》,該產品分類編碼為10,管理類別為第三類。本文件與“國械注準20193100207”註冊證共同使用。批准日期為2019年10月28日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.